In the BioHarmony Drug Report Database
Somapacitan-beco
Sogroya (somapacitan) is a small molecule pharmaceutical. Somapacitan was first approved as Sogroya on 2021-03-31. It has been approved in Europe to treat growth.
Trade Name
|
Sogroya |
|---|---|
Common Name
|
somapacitan |
ChEMBL ID
|
CHEMBL3707290 |
Indication
|
growth |
Drug Class
|
Growth hormone derivatives |
Image (chem structure or protein)